David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D. 

Slides:



Advertisements
Similar presentations
High frequency of discordance between antimüllerian hormone and follicle-stimulating hormone levels in serum from estradiol-confirmed days 2 to 4 of the.
Advertisements

Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles  Ryan G. Steward,
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Grace Younes, M.D., Togas Tulandi, M.D., M.H.C.M. 
Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimüllerian.
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
A giant oocyte in a cohort of retrieved oocytes: does it have any effect on the in vitro fertilization cycle outcome?  Ronit Machtinger, M.D., Joseph.
Nicole Banks, M. D. , George Patounakis, M. D. , Ph. D
Antral follicle count (AFC) can be used in the prediction of ovarian response but cannot predict the oocyte/embryo quality or the in vitro fertilization.
Gonadotropin-releasing hormone agonist trigger increases the number of oocytes and embryos available for cryopreservation in cancer patients undergoing.
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization–intracytoplasmic.
Antimüllerian hormone levels and numbers and sizes of antral follicles in regularly menstruating women of reproductive age referenced to true ovulation.
Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study 
Patient-tailored ovarian stimulation for in vitro fertilization
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages  Maribel.
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
High serum FSH levels in men with nonobstructive azoospermia does not affect success of microdissection testicular sperm extraction  Ranjith Ramasamy,
Boback M. Berookhim, M. D. , M. B. A. , Gianpiero D. Palermo, M. D
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth  Scott M. Nelson, M.R.C.O.G.,
Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.
Mohamad Irani, M. D. , David Reichman, M. D. , Alex Robles, M. D
Orhan Bukulmez, M. D. , Qin Li, M. S. , Bruce R. Carr, M. D
The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count  Simone L. Broer, B.Sc., Ben Willem J.
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.
Elevated body mass index is associated with lower serum anti-mullerian hormone levels in infertile women with diminished ovarian reserve but not with.
In vitro fertilization for Orthodox Jewish couples: antagonist cycle modifications allowing for mikveh attendance before oocyte retrieval  David E. Reichman,
Oocyte cryopreservation
Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis?  Emanuela Stochino-Loi,
Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.
Lena Dain, M. D. , David Bider, M. D. , Jacob Levron, M. D
Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool  Richard.
Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes  Aaron.
Effect of Salpingectomy on Ovarian Reserve: A Systematic Review and Meta-Analysis  C.E. Boots, MD, E.A. Seidler, MD, A. Ainsworth, MD, A. Hardi, MLIS,
The effectiveness of gonadotropin-releasing hormone antagonist in poor ovarian responders undergoing in vitro fertilization: a systematic review and meta-analysis 
Nigel Pereira, M. D. , Hency H. Patel, B. S. , Logan D. Stone, B. A
Introduction Fertility and Sterility
From partner's desk to iPad
Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis  Reshef Tal,
Comparison of antimüllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis.
Impact of oocyte donation on perinatal outcome in twin pregnancies
Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection  Dorothea M.
Stephanie L. F. Gustin, M. D. , Gourab Mukherjee, Valerie L. Baker, M
Efficacy and safety of human chorionic gonadotropin for follicular phase stimulation in assisted reproduction: a systematic review and meta-analysis 
Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities.
In vitro fertilization versus conversion to intrauterine insemination in the setting of three or fewer follicles: how should patients proceed when follicular.
David E. Reichman, M. D. , Stacey A. Missmer, Sc. D. , Katharine F
Predictive usefulness of cycle day 10 follicle-stimulating hormone level in a clomiphene citrate challenge test for in vitro fertilization outcome in.
Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation  Allison Styne-Gross, M.D., Karen.
Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin  Samuel S. Thatcher, M.D., Ph.D., Elizabeth M.
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing 
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.
Moderately elevated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify.
Relationship between maternal age and aneuploidy in in vitro fertilization pregnancy loss  Steven D Spandorfer, M.D., Owen K Davis, M.D., Larry I Barmat,
Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss  Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,
Thin endometrial stripe does not affect likelihood of achieving pregnancy in clomiphene citrate/intrauterine insemination cycles  Albert Asante, M.D.,
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients  Scott M. Nelson, Ph.D., Martina C. Messow,
David H. Barad, M.D., M.S., Norbert Gleicher, M.D. 
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories  Melissa C. Yih, M.D.,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Fertility in patients with congenital adrenal hyperplasia
Intrafollicular antimüllerian hormone levels predict follicle responsiveness to follicle- stimulating hormone (FSH) in normoandrogenic ovulatory women.
Ongoing pregnancy rates in intrauterine insemination are affected by late follicular- phase progesterone levels  Antonio Requena, M.D., María Cruz, Ph.D.,
A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Logarithmic curves depicting initial level and rise of serum beta human chorionic gonadotropin and live delivery outcomes with in vitro fertilization:
Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment  Daniel Bodri, M.D., M.Sc.,
Ernesto Bosch, M. D. , Elena Labarta, M. D
Presentation transcript:

Value of antimüllerian hormone as a prognostic indicator of in vitro fertilization outcome  David E. Reichman, M.D., Dan Goldschlag, M.D., Zev Rosenwaks, M.D.  Fertility and Sterility  Volume 101, Issue 4, Pages 1012-1018.e1 (April 2014) DOI: 10.1016/j.fertnstert.2013.12.039 Copyright © 2014 Terms and Conditions

Figure 1 (A) Correlation between AMH and number of oocytes retrieved (stratified by age). (B) Correlation between FSH and number of oocytes retrieved (stratified by AMH level). Fertility and Sterility 2014 101, 1012-1018.e1DOI: (10.1016/j.fertnstert.2013.12.039) Copyright © 2014 Terms and Conditions

Figure 2 Receiver operating characteristic curves for prediction of (A) number of oocytes retrieved and (B) ongoing pregnancy. Fertility and Sterility 2014 101, 1012-1018.e1DOI: (10.1016/j.fertnstert.2013.12.039) Copyright © 2014 Terms and Conditions

Supplemental Figure 1 Correlation between AFC and number of oocytes retrieved. Fertility and Sterility 2014 101, 1012-1018.e1DOI: (10.1016/j.fertnstert.2013.12.039) Copyright © 2014 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.